Random triples
| Subject | Object |
|---|---|
| gptkb:Interferon_beta-1a | bioavailability 50-60% (subcutaneous) |
| gptkb:emicizumab | linear |
| gptkb:daratumumab | half-life ~18 days |
| gptkb:Ipilimumab | linear |
| gptkb:Prolia | linear |
| gptkb:Daratumumab | linear |
| gptkb:evolocumab | linear at low doses, nonlinear at high doses |
| gptkb:Darzalex | half-life 18 days |
| gptkb:filgrastim | linear |
| gptkb:ipilimumab | linear |
| gptkb:Amivantamab | half-life ~11 days |
| gptkb:Nivolumab | linear |